Options
Tsioutis, Constantinos
Loading...
Preferred name
Tsioutis, Constantinos
Translated Name
Τσιούτης, Κωνσταντίνος
Main Affiliation
School
Department
Web Site
Scopus Author ID
23020364100
Google Scholar ID
coc4BCMAAAAJ
2 results
Now showing 1 - 2 of 2
- PublicationNot surprising: a rebound in antibacterial consumption in Europe, with Cyprus and Greece on the podiumRecent European-wide data place Cyprus and Greece in the highest positions of total antimicrobial consumption. While this level of consumption might be partly attributed to the high rates of infections due to MDR bacteria in these countries, several other reasons should be sought to help apply local measures, to decrease inappropriate and excess antimicrobial use. The present viewpoint aims to provide a roadmap for interventions, by briefly discussing the various factors that underlie antimicrobial use and prescribing practices in Greece and Cyprus.
- PublicationExtensive Testing and Public Health Interventions for the Control of COVID-19 in the Republic of Cyprus between March and May 2020(MDPI, 2020-11)
; ;Annalisa Quattrocchi ;Ioannis Mamais ;Eirini Christaki ;Costas Constantinou ;Maria Koliou ;Zoi-Dorothea Pana ;Valentinos Silvestros ;Fani Theophanous ;Christos Haralambous ;Androulla Stylianou ;Sotiroula Sotiriou ;Maria Athanasiadou ;Theopisti Kyprianou ;Anna Demetriou ;Christiana A. Demetriou ;Ourania Kolokotroni ;Ioanna Gregoriou ;Niki Paphitou ;George Panos ;Leontios Kostrikis ;Peter Karayiannis ;Georgios Petrikkos ;Petros Agathangelou ;George Mixides ;Georgios Siakallis ;Linos Hadjihannas ;Lakis Palazis ;Anna Vavlitou ;Chrystalla Matsentidou-Timiliotou ;Dimitris Koukios ;Tonia Adamidi ;Frangiskos Frangopoulos ;Elizabeth ConstantinouGeorgios NikolopoulosCoronavirus disease 2019 (COVID-19) has significantly affected the well-being of individuals worldwide. We herein describe the epidemiology of COVID-19 in the Republic of Cyprus during the first epidemic wave (9 March–3 May 2020). We analyzed surveillance data from laboratory-confirmed cases, including targeted testing and population screening. Statistical analyses included logistic regression. During the surveillance period, 64,136 tests (7322.3 per 100,000) were performed, 873 COVID-19 cases were diagnosed, and 20 deaths were reported (2.3%). Health-care workers (HCWs) represented 21.4% of cases. Overall, 19.1% of cases received hospital care and 3.7% required admission to Intensive Care Units. Male sex (adjusted Odds Ratio (aOR): 3.04; 95% Confidence Interval (CI): 1.97–4.69), increasing age (aOR: 1.56; 95%CI: 1.36–1.79), symptoms at diagnosis (aOR: 6.05; 95%CI: 3.18–11.50), and underlying health conditions (aOR: 2.08; 95%CI: 1.31–3.31) were associated with hospitalization. For recovered cases, the median time from first to last second negative test was 21 days. Overall, 119 primary cases reported 616 close contacts, yielding a pooled secondary attack rate of 12% (95%CI: 9.6–14.8%). Three population-based screening projects, and two projects targeting employees and HCWs, involving 25,496 people, revealed 60 positive individuals (0.2%). Early implementation of interventions with targeted and expanded testing facilitated prompt outbreak control on the island.